Skip to main content
Log in

Apixaban zur Behandlung venöser Thrombembolien bei Krebspatienten

Apixaban for the treatment of venous thromboembolism in cancer patients

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484–3488

    Article  CAS  Google Scholar 

  2. Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A (2020) Venous Thromboembolism prophylaxis and treatment in patients with cancer: aSCO clinical practice guideline update. J Clin Oncol 38(5):496–520

    Article  Google Scholar 

  3. Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR, Hokusai VTE Cancer Investigators (2018) Edoxaban for the treatment of cancer-associated venous Thromboembolism. N Engl J Med 378(7):615–624

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hakan Alakus.

Ethics declarations

Interessenkonflikt

A.G. Barutcu, H. Alakus und C. Bruns geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barutcu, A.G., Alakus, H. & Bruns, C. Apixaban zur Behandlung venöser Thrombembolien bei Krebspatienten. Onkologe 26, 758–759 (2020). https://doi.org/10.1007/s00761-020-00783-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-020-00783-w

Navigation